Becton Dickinson and Co (NYSE:BDX)

119.38
Data as of Jul 30
 +0.52 / +0.44%
Today’s Change
96.73
Today|||52-Week Range
120.66
+8.05%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$23.0B

Company Description

Becton, Dickinson & Co. is a global medical technology company. The company is engaged in the development, manufacture and sale of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. The company operates through three worldwide business segments: BD Medical, BD Diagnostics and BD Biosciences. The BD Medical segment produces medical devices that are used in a wide range of healthcare settings. This segment product include needles, syringes and intravenous catheters for medication delivery; prefilled IV flush syringes; syringes and pen needles for the self-injection of insulin and other drugs used in the treatment of diabetes. The BD Diagnostics segment provides products for the safe collection and transport of diagnostics specimens, as well as instrument systems and reagents to detect a broad range of infectious diseases, healthcare-associated infections and cancers. This segment products include integrated systems for specimen collection; safety-engineered blood collection products and systems; automated blood culturing systems; molecular testing systems for infectious diseases and women's health; microorganism identification and drug susceptibility systems; liquid-based cytology systems for cervical cancer screening; rapid diagnostic assays; microbiology laboratory automation; and plated media. The BD Biosciences segment produces research and clinical tools that facilitate the study of cells, and the components of cells, to gain a better understanding of normal and disease processes. This segment product include fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; cell imaging systems; diagnostic assays; and cell culture media supplements for biopharmaceutical manufacturing. Becton, Dickinson & Co. was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.

Contact Information

Becton, Dickinson & Co.
1 Becton Drive
Franklin Lakes New Jersey 07417-1880
P:(201) 847-6800
Investor Relations:
(201) 847-5369

Employees

Shareholders

Other institutional47.34%
Mutual fund holders40.37%
Individual stakeholders0.89%

Top Executives

Vincent A. ForlenzaChairman, President & Chief Executive Officer
William A. KozyChief Operating Officer & Executive Vice President
Christopher R. ReidyChief Financial Officer & EVP-Administration
Scott P. BruderSVP, Chief Science & Technology Officer
Ellen R. StrahlmanChief Medical Officer, SVP-Research & Development

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.